Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04703686
Title Treatment by a Bispecific CD3xCD20 Antibody for Relapse/Refractory Lymphomas After CAR T-cells Therapy
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors The Lymphoma Academic Research Organisation
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
CHU de Clermont Ferrand Clermont Ferrand 63000 France Details
Hopital Henri Mondor Créteil 94010 France Details
CHU de Dijon - Hôpital le Bocage Dijon 21034 France Details
CHRU Lille - Hôpital Claude Huriez Lille 59037 France Details
CHU Montpellier Montpellier 34295 France Details
CHU Nantes Nantes 44093 France Details
Hôpital Saint Louis Paris 75475 France Details
APHP - Hôpital de la Pitiè Salpetrière Paris France Details
APHP - Hôpital Saint Antoine Paris France Details
CHU de Bordeaux - Hôpital Haut Leveque Pessac 33604 France Details
CHU Lyon Sud Pierre Bénite 69130 France Details
CHU de Rennes - Hôpital Pontchaillou Rennes 35033 France Details
Centre Henri Becquerel Rouen 76038 France Details
IUCT Oncopole Toulouse 31059 France Details
CHU de Brabois Vandoeuvre les Nancy France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field